These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21518497

  • 1. [Comparison of curative efficacy after G-CSF-mobilized sibling HLA-matched peripheral blood hematopoietic stem cell transplantation versus that combined with BMT for patients with hematologic malignancies in a single center].
    Ren FP, Liu HL, Sun ZM, Geng LQ, Wang XB, Ding KY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):404-9. PubMed ID: 21518497
    [Abstract] [Full Text] [Related]

  • 2. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
    Ostronoff F, Ostronoff M, Souto-Maior AP, Domingues M, Sucupira A, Manso DA, de Lima AK, Monteiro PG, Florêncio R, Calixto R.
    Clin Transplant; 2009 Apr; 23(1):33-8. PubMed ID: 18727660
    [Abstract] [Full Text] [Related]

  • 3. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
    Chen X, Wei JL, Huang Y, He Y, Yang DL, Jiang EL, Ma QL, Zhou LK, Lin XT, Shen YY, Feng SZ, Han MZ.
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
    [Abstract] [Full Text] [Related]

  • 4. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM, Bandini G, Leopardi G, Rosti G, Bonini A, Fortuna A, Rondelli D, Mangianti S, Motta MR, Rizzi S, Tassi C, Cavo M, Remiddi C, Curti A, Conte R, Tura S.
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [Abstract] [Full Text] [Related]

  • 5. Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation.
    Lapierre V, Aupérin A, Tayebi H, Chabod J, Saas P, Michalet M, François S, Garban F, Giraud C, Tramalloni D, Oubouzar N, Blaise D, Kuentz M, Robinet E, Tiberghien P, Société Française de Greffe de Moelle et de Thérapiue Cellulaire.
    Blood; 2002 Aug 15; 100(4):1484-9. PubMed ID: 12149235
    [Abstract] [Full Text] [Related]

  • 6. [A clinical study of haploidentical transplantation using granulocyte colony-stimulating factor stimulating donor bone marrow].
    Chen H, Ji S, Wang H.
    Zhonghua Nei Ke Za Zhi; 2001 Nov 15; 40(11):760-3. PubMed ID: 11930684
    [Abstract] [Full Text] [Related]

  • 7. [Peripheral blood stem cell transplantation for 53 patients with malignant hematologic diseases].
    Xie XS, Wan DM, Sun H, Sun L, Liu LX, Jiang ZX.
    Ai Zheng; 2007 Apr 15; 26(4):403-6. PubMed ID: 17430661
    [Abstract] [Full Text] [Related]

  • 8. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S, Bishop MR, Tarantolo S, Cowles MK, Reed E, Anderson JR, Vose JM, Bierman P, Armitage JO, Kessinger A.
    Exp Hematol; 1995 Dec 15; 23(14):1503-8. PubMed ID: 8542938
    [Abstract] [Full Text] [Related]

  • 9. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R, Enczmann J, Balzer S, Bernbeck B, Kramm C, Schönberger S, Sinha K, Tröger A, Wernet P, Göbel U, Laws HJ, Dilloo D.
    Klin Padiatr; 2005 Dec 15; 217(3):135-41. PubMed ID: 15858704
    [Abstract] [Full Text] [Related]

  • 10. G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
    Remberger M, Naseh N, Aschan J, Barkholt L, LeBlanc K, Svennberg P, Ringdén O.
    Bone Marrow Transplant; 2003 Jul 15; 32(2):217-23. PubMed ID: 12838288
    [Abstract] [Full Text] [Related]

  • 11. Comparative analysis of unrelated cord blood transplantation and HLA-matched sibling hematopoietic stem cell transplantation in children with high-risk or advanced acute leukemia.
    Zheng C, Zhu X, Tang B, Yao W, Song K, Tong J, Geng L, Liu H, Sun Z.
    Ann Hematol; 2015 Mar 15; 94(3):473-80. PubMed ID: 25217231
    [Abstract] [Full Text] [Related]

  • 12. Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia.
    Zhao XS, Chen Y, Zhao XY, Liu DH, Xu LP, Wang Y, Han W, Chen YH, Chen H, Zhang XH, Liu KY, Huang XJ.
    Clin Transplant; 2013 Mar 15; 27(6):844-51. PubMed ID: 23992032
    [Abstract] [Full Text] [Related]

  • 13. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C, Martinez C, Brunet S, Tomás JF, Urbano-Ispizua A, Zuazu J, Ojeda E, Bargay J, Moraleda JM, Bailen A, Sierra J, García-Conde J, Rozman C.
    Bone Marrow Transplant; 1998 Dec 15; 22(12):1129-35. PubMed ID: 9894714
    [Abstract] [Full Text] [Related]

  • 14. MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings.
    Piñana JL, Valcárcel D, Fernández-Avilés F, Martino R, Rovira M, Barba P, Martínez C, Brunet S, Sureda A, Carreras E, Sierra J.
    Bone Marrow Transplant; 2010 Sep 15; 45(9):1449-56. PubMed ID: 20140024
    [Abstract] [Full Text] [Related]

  • 15. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S, Niehues T, Meisel R, Bernbeck B, Laws HJ, Kögler G, Enzmann J, Wernet P, Göbel U, Dilloo D.
    Klin Padiatr; 2004 Sep 15; 216(6):356-63. PubMed ID: 15565551
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
    Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, Atsuta Y, Kanda J, Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy.
    Cytotherapy; 2024 Aug 15; 26(8):910-920. PubMed ID: 38639671
    [Abstract] [Full Text] [Related]

  • 17. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY.
    Biol Blood Marrow Transplant; 2009 Feb 15; 15(2):266-73. PubMed ID: 19167687
    [Abstract] [Full Text] [Related]

  • 18. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
    Huang X, Liu D.
    Clin Transpl; 2011 Feb 15; ():237-45. PubMed ID: 22755417
    [Abstract] [Full Text] [Related]

  • 19. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H, Wake A, Yamasaki Y, Izumi Y.
    Rinsho Ketsueki; 2000 Jun 15; 41(6):500-6. PubMed ID: 10921350
    [Abstract] [Full Text] [Related]

  • 20. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul 15; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.